A condition known as eosinophilic esophagitis, or EoE, affects one in 1,500 kids. They actually have an allergic reaction ...

AstraZeneca’s FASENRA ® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). 1 EGPA is a rare, immune-mediated ...

The partnership will see AI-enabled screening used to address bioavailability issues with Equillium’s cytokine-targeting ...

Researchers assess the airway microbiome and host immune-inflammatory responses to identify treatable aspects of severe ...

Vivtex to apply its GI-ORIS™ technology to optimize oral bioavailability of EQ302, Equillium’s novel IL-15/IL-21 bi-specific peptide ...

Eupraxia Pharmaceuticals has disclosed additional positive data from its Phase Ib/IIa RESOLVE clinical trial of EP-104GI in treating eosinophilic esophagitis (EoE). The multicentre, open-label, ...

For patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, ...

In these phase 3A, randomized, placebo-controlled replicate trials, we evaluated the efficacy and safety of depemokimab in patients with severe asthma and an eosinophilic ... (P.E.P.), and GSK ...

From the Department of Internal Medicine, Lahey Clinic. † Member, Department of Internal Medicine, Lahey Clinic. ‡ Member, Department of Internal Medicine, Lahey Clinic (on leave of absence.) ...

There is moderate to abundant eosinophilic cytoplasm (×20 ... Neuroendocrine markers (d) synaptophysin and (e) chromogranin are positive in tumor cells (×20), and (f) proliferation labeling index with ...

Degenerated urothelial cells present with shrunken (condensed), dark nuclei with mildly irregular nuclear borders, granular cytoplasm, and eosinophilic and/or cyanophilic intracytoplasmic inclusions ...